Vanda Pharmaceuticals Inc.VNDANASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 248 | 269↑8.3% | 254↓5.3% | 193↓24.3% | 199↑3.2% |
| Gross Profit | 225 | 243↑8.1% | 230↓5.3% | 178↓22.7% | 187↑5.4% |
| Operating Income | 27 | 42↑54.8% | 6↓85.0% | -14↓320.4% | -41↓191.4% |
| Net Income | 23 | 33↑42.1% | 6↓81.1% | 3↓60.0% | -19↓853.3% |
| EBITDA | 35 | 45↑30.4% | 9↓79.9% | -11↓220.7% | -33↓197.3% |
| EPS Diluted | 0.42 | 0.58↑38.1% | 0.11↓81.0% | 0.04↓60.4% | -0.32↓833.9% |